|
|
- Issue Information
Abstract: Neuropsychopharmacology Reports, Volume 42, Issue 1, Page 1-2, March 2022.
PubDate: 2022-03-14T01:15:04-07:00
DOI: 10.1002/npr2.12184
Issue No: Vol. 42, No. 1 (2022)
- Relationship between the early repolarization pattern and a history of
suicide attempts among drug‐free psychiatric patients
Authors:
Hiroshi Kameyama; Kenichi Sugimoto,
Fumitoshi Kodaka,
Kyoko Ito,
Kazutaka Nukariya,
Tomohiro Kato,
Masahiro Shigeta
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-05-04T05:19:04-07:00
DOI: 10.1002/npr2.12254
- Perospirone augmentation of escitalopram in the treatment of an adolescent
sophophobia (fear of learning) patient
Authors:
Kensuke Miyazaki
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-05-04T04:34:37-07:00
DOI: 10.1002/npr2.12256
- Prenatal methotrexate injection increases behaviors possibly associated
with depression and/or autism in rat offspring; A new animal model for
mental disorder, based on folate metabolism deficit during pregnancy
Authors:
Naoki Amada; Yusuke Kakumoto,
Takashi Futamura,
Kenji Maeda
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-05-03T01:39:45-07:00
DOI: 10.1002/npr2.12255
- Identification of factors associated with the efficacy of atomoxetine in
adult attention‐deficit/hyperactivity disorder
Authors:
Tsutomu Nagai; Tatsuya Kurihara,
Hiroaki Koya,
Yukako Nakano,
Satoru Sugisawa,
Takehiko Sambe,
Keiko Kishimoto,
Mari Kogo,
Haruhisa Ota,
Akira Iwanami,
Naoki Uchida
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-04-29T03:50:50-07:00
DOI: 10.1002/npr2.12253
- Role of noradrenergic transmission within the ventral bed nucleus of the
stria terminalis in nicotine withdrawal‐induced aversive behavior
Authors:
Saya Arakaki; Masabumi Minami
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-04-19T12:29:15-07:00
DOI: 10.1002/npr2.12252
- COVID‐19 vaccination did not improve employee mental health: A
prospective study in an early phase of vaccination in Japan
Authors:
Natsu Sasaki; Reiko Kuroda,
Kanami Tsuno,
Kotaro Imamura,
Norito Kawakami
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-04-12T12:44:18-07:00
DOI: 10.1002/npr2.12250
- Fluphenazine decanoate‐induced bradycardia: A case report
Authors:
Mahsa Kamali; Mehran Zarghami,
Marzieh Azizi,
Forouzan Elyasi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-04-03T06:22:49-07:00
DOI: 10.1002/npr2.12251
- Relationship between autistic traits and social functioning in healthy
individuals
Authors:
Yuria Demizu; Junya Matsumoto,
Yuka Yasuda,
Satsuki Ito,
Kenichiro Miura,
Hidenaga Yamamori,
Michiko Fujimoto,
Naomi Hasegawa,
Keiichiro Ishimaru,
Ryota Hashimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-04-01T11:39:11-07:00
DOI: 10.1002/npr2.12249
- A 12‐session relapse prevention program vs psychoeducation in the
treatment of Japanese alcoholic patients: A randomized controlled trial
Authors:
Takayuki Harada; Yuzo Aikawa,
Mihoko Takahama,
Yosuke Yumoto,
Mitsuru Umeno,
Yukako Hasegawa,
Shigeo Ohsawa,
Nozomu Asukai
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-27T11:14:34-07:00
DOI: 10.1002/npr2.12248
- Clinical characteristics and treatment outcomes of patients with newly
diagnosed schizophrenia: A 4‐year single‐center experience in Saudi
Arabia
Authors:
Tahir Hakami
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-22T09:59:41-07:00
DOI: 10.1002/npr2.12247
- Subjective assessment of participants in education programs on clinical
practice guidelines in the field of psychiatry
Authors:
Kazuyoshi Ogasawara; Shusuke Numata,
Naomi Hasegawa,
Masahito Nakataki,
Manabu Makinodan,
Kazutaka Ohi,
Masahiro Takeshima,
Takashi Tsuboi,
Naoki Hashimoto,
Toshiaki Onitsuka,
Hiroyuki Muraoka,
Hikaru Hori,
Kayo Ichihashi,
Takahiko Inagaki,
Norio Yasui‐Furukori,
Akitoyo Hishimoto,
Nobuhiro Sugiyama,
Kentaro Fukumoto,
Tatsuya Nagasawa,
Junya Matsumoto,
Yoshikazu Takaesu,
Ryuji Furihata,
Kiyotaka Nemoto,
Toshinori Nakamura,
Masahide Usami,
Kenichiro Miura,
Michiko Fujimoto,
Hiromi Tagata,
Hisashi Yamada,
Hiroshi Komatsu,
Shinichiro Ochi,
Kiyokazu Atake,
Eiichi Katsumoto,
Mikio Kido,
Taishiro Kishimoto,
Taro Suwa,
Satoshi Yamamura,
Jun‐ichi Iga,
Hitoshi Iida,
Ken Inada,
Koichiro Watanabe,
Ryota Hashimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-10T04:39:05-08:00
DOI: 10.1002/npr2.12245
- Development of attentional networks during childhood and adolescence: A
functional MRI study
Authors:
Daisuke N. Saito; Takashi X. Fujisawa,
Hisakazu T. Yanaka,
Takeshi Fujii,
Takanori Kochiyama,
Kai Makita,
Akemi Tomoda,
Hidehiko Okazawa
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-09T08:24:30-08:00
DOI: 10.1002/npr2.12246
- Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute
psychiatric symptoms in children'
Authors:
Anaël Ayrolles; Pierre Ellul,
Vincent Trebossen,
Nadira Houhou‐Fidouh,
Stephane Bonacorsi,
Diane Descamps,
Richard Delorme
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-08T12:44:10-08:00
DOI: 10.1002/npr2.12236
- Retention and impairment of neurocognitive functions in mild cognitive
impairment and Alzheimer’s disease with a comprehensive
neuropsychological test
Authors:
Lu Yao; Shinsuke Aoyama,
Atushi Ouchi,
Yasuji Yamamoto,
Ichiro Sora
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-05T12:56:51-08:00
DOI: 10.1002/npr2.12243
- Efficacy of clozapine for long‐stay patients with treatment‐resistant
schizophrenia: 4‐year observational study
Authors:
Kentaro Mizuno; Emiko Mizuno,
Akira Suekane,
Toshiaki Shiratsuchi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-03-02T02:48:16-08:00
DOI: 10.1002/npr2.12244
- Safety and tolerability of aripiprazole in patients with psychosis
Authors:
Kenichi Kashihara; Tetsuya Maeda,
Kazuto Yoshida
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-28T07:59:09-08:00
DOI: 10.1002/npr2.12235
- Aripiprazole LAI two‐injection start in a 16 year‐old
adolescent with schizophrenia
Authors:
Virginio Salvi; Cristina Appignanesi,
Brodinela Marpepa,
Laura Orsolini,
Umberto Volpe
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-19T12:39:29-08:00
DOI: 10.1002/npr2.12240
- Effectiveness of progressive muscle relaxation technique on anxiety caused
by Covid‐19 in pregnant women: A randomized clinical trial
Authors:
Mojgan Zendehdel; Forouzan Elyasi,
Shayesteh Jahanfar,
Azam Emami‐Sahebi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-18T11:53:24-08:00
DOI: 10.1002/npr2.12241
- Association between psychotropic prescriptions and the total amount of
psychotropics ingested during an intentional overdose: A single‐center
retrospective study
Authors:
Iori Tanahashi; Takafumi Shiganami,
Takayuki Iwayama,
Taisei Wake,
Sayaka Kobayashi,
Haruo Yoshimasu
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-16T09:33:54-08:00
DOI: 10.1002/npr2.12242
- Psychological stress of emergency medical staff after the largest mass
murder incident in post‐World War II era
Authors:
Hisatoshi Arai; Katsuo Inoue,
Takeya Takizawa,
Tatsuhiro Yamaya,
Yasushi Asari,
Hitoshi Miyaoka
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-16T08:59:39-08:00
DOI: 10.1002/npr2.12237
- A case report: Clozapine‐induced leukopenia and neutropenia after mRNA
COVID‐19 vaccination
Authors:
Tomoyuki Imai; Sho Ochiai,
Takehiro Ishimaru,
Hayato Daitoku,
Yusuke Miyagawa,
Ryuji Fukuhara,
Shuken Boku,
Minoru Takebayashi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-15T03:04:15-08:00
DOI: 10.1002/npr2.12238
- Multisectoral actions of mental health during the COVID‐19 pandemic in
Mazandaran province of Iran
Authors:
Abdolkarim Ahmadi Livani; Farzad Gohardehi,
Marzieh Azizi,
Mahmoud Reza Hashemvarzi,
Somayeh Taghavi,
Sara Tonekaboni,
Ramzanali Golchobi,
Mehran Zarghami,
Mohsen Aarabi,
Forouzan Elyasi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-14T11:12:39-08:00
DOI: 10.1002/npr2.12239
- Evaluation of a natural S‐equol supplement in treating premenstrual
symptoms and the effect of the gut microbiota: An open‐label pilot study
Authors:
Takashi Takeda; Yasutaka Chiba
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-06T11:01:19-08:00
DOI: 10.1002/npr2.12234
- Alfaxalone improved in acute stress‐induced tactile hypersensitivity and
anxiety‐like behavior in mice
Authors:
Kazumi Yoshizawa; Saki Ukai,
Junpei Kuroda,
Tsugumi Yamauchi,
Daisuke Yamada,
Akiyoshi Saitoh,
Satoshi Iriyama,
Shoichi Nishino,
Satoru Miyazaki
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-04T12:38:13-08:00
DOI: 10.1002/npr2.12233
- Association between eating balanced meals and depressive symptoms in
Japanese hospital workers during the COVID‐19 pandemic
Authors:
Takako Miki; Shohei Yamamoto,
Ami Fukunaga,
Yosuke Inoue,
Hironori Ishiwari,
Masamichi Ishii,
Kengo Miyo,
Maki Konishi,
Norio Ohmagari,
Tetsuya Mizoue
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-02-02T01:39:42-08:00
DOI: 10.1002/npr2.12230
- Relationship of food allergy with quality of life and sleep in psychiatric
patients
Authors:
Chiho Gomi; Yuuki Yokota,
Sumiko Yoshida,
Hiroshi Kunugi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-28T09:15:40-08:00
DOI: 10.1002/npr2.12231
- Changes in median eminence of fatty acid–binding protein 3 in a
mouse model of pain
Authors:
Dan Tachibana; Kazuo Nakamoto,
Shogo Tokuyama
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-28T09:14:07-08:00
DOI: 10.1002/npr2.12225
- Risk factors for readmission in schizophrenia treated with combined
psychoeducation and standard therapy
Authors:
Satoru Sugisawa; Tatsuya Kurihara,
Yukako Nakano,
Toshiaki Tsuneoka,
Hiroaki Koya,
Tsutomu Nagai,
Tomohiro Ikeda,
Naoko Fujisawa,
Atsuko Inamoto,
Akira Iwanami
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-26T01:39:32-08:00
DOI: 10.1002/npr2.12229
- Gut permeability and its clinical relevance in schizophrenia
Authors:
Ikki Ishida; Jun Ogura,
Emiko Aizawa,
Miho Ota,
Shinsuke Hidese,
Yukihito Yomogida,
Junko Matsuo,
Sumiko Yoshida,
Hiroshi Kunugi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-25T11:38:16-08:00
DOI: 10.1002/npr2.12227
- Ifenprodil for the treatment of methamphetamine use disorder: An
exploratory, randomized, double‐blind, placebo‐controlled trial
Authors:
Hiroko Kotajima‐Murakami; Ayumi Takano,
Shinya Hirakawa,
Yasukazu Ogai,
Daisuke Funada,
Yuko Tanibuchi,
Eriko Ban,
Minako Kikuchi,
Hisateru Tachimori,
Kazushi Maruo,
Takahiro Kawashima,
Yui Tomo,
Tsuyoshi Sasaki,
Hideki Oi,
Toshihiko Matsumoto,
Kazutaka Ikeda
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-23T10:53:02-08:00
DOI: 10.1002/npr2.12232
- Acute and chronic effects of oral administration of a medium‐chain fatty
acid, capric acid, on locomotor activity and anxiety‐like and
depression‐related behaviors in adult male C57BL/6J mice
Authors:
Hirotaka Shoji; Hiroshi Kunugi,
Tsuyoshi Miyakawa
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-07T02:34:12-08:00
DOI: 10.1002/npr2.12226
- The effectiveness of lamotrigine for persistent depressive disorder: A
case report
Authors:
Yusuke Matsuzaka; Kayoko Urashima,
Shintaro Sakai,
Yoshiro Morimoto,
Shinji Kanegae,
Hirohisa Kinoshita,
Akira Imamura,
Hiroki Ozawa
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-01-05T10:21:59-08:00
DOI: 10.1002/npr2.12228
- Tubulin/microtubules as novel clozapine targets
Authors:
Mizuki Hino; Takeshi Kondo,
Yasuto Kunii,
Junya Matsumoto,
Akira Wada,
Shin‐ichi Niwa,
Mitsutoshi Setou,
Hirooki Yabe
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-12-28T10:45:11-08:00
DOI: 10.1002/npr2.12221
- Serial case report of high seizure threshold patients that responded to
the lengthening of pulse width in ECT
Authors:
Hiroshi Katagai; Norio Yasui‐Furukori,
Hirotsugu Kawashima,
Taro Suwa,
Chieko Tsushima,
Yoshiteru Sato,
Kazutaka Shimoda,
Hiroichi Tasaki
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-12-24T10:53:10-08:00
DOI: 10.1002/npr2.12224
- Improved cognitive function in patients with major depressive disorder
after treatment with vortioxetine: A EEG study
Authors:
Hong Kim; Seung Yeon Baik,
Yong Wook Kim,
Seung‐Hwan Lee
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-12-10T10:39:43-08:00
DOI: 10.1002/npr2.12220
- Severe and long‐lasting neuropsychiatric symptoms after mild respiratory
symptoms caused by COVID‐19: A case report
Authors:
Ryosuke Jozuka; Hiroki Kimura,
Takashi Uematsu,
Hidetsugu Fujigaki,
Yasuko Yamamoto,
Masato Kobayashi,
Kazuya Kawabata,
Haruki Koike,
Toshiya Inada,
Kuniaki Saito,
Masahisa Katsuno,
Norio Ozaki
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-12-10T03:04:15-08:00
DOI: 10.1002/npr2.12222
- Searching for biomarkers in schizophrenia and psychosis: Case‐control
study using capillary electrophoresis and liquid chromatography
time‐of‐flight mass spectrometry and systematic review for biofluid
metabolites
Authors:
Saehyeon Kim; Satoshi Okazaki,
Ikuo Otsuka,
Yutaka Shinko,
Tadasu Horai,
Naofumi Shimmyo,
Takashi Hirata,
Naruhisa Yamaki,
Takaki Tanifuji,
Shuken Boku,
Ichiro Sora,
Akitoyo Hishimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-12-08T11:50:10-08:00
DOI: 10.1002/npr2.12223
- Association between the examination rate of treatment‐resistant
schizophrenia and the clozapine prescription rate in a nationwide
dissemination and implementation study
Authors:
Norio Yasui‐Furukori; Hiroyuki Muraoka,
Naomi Hasegawa,
Shinichiro Ochi,
Shusuke Numata,
Hikaru Hori,
Akitoyo Hishimoto,
Toshiaki Onitsuka,
Kazutaka Ohi,
Naoki Hashimoto,
Tatsuya Nagasawa,
Yoshikazu Takaesu,
Takahiko Inagaki,
Hiromi Tagata,
Takashi Tsuboi,
Chika Kubota,
Ryuji Furihata,
Jun‐ichi Iga,
Hitoshi Iida,
Kenichiro Miura,
Junya Matsumoto,
Hisashi Yamada,
Koichiro Watanabe,
Ken Inada,
Kazutaka Shimoda,
Ryota Hashimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-12-02T12:42:37-08:00
DOI: 10.1002/npr2.12218
- Development and acceptability of a decision aid for chronic insomnia
considering discontinuation of benzodiazepine hypnotics
Authors:
Yumi Aoki; Yoshikazu Takaesu,
Masahiro Suzuki,
Isa Okajima,
Masahiro Takeshima,
Akiyoshi Shimura,
Tomohiro Utsumi,
Nozomu Kotorii,
Hidehisa Yamashita,
Kenichi Kuriyama,
Norio Watanabe,
Kazuo Mishima
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2021-11-22T05:47:55-08:00
DOI: 10.1002/npr2.12219
|
Open Access journal
